Method for detecting dissolution rates of acetylkitasamycin capsules

A technology for the detection of acetylkitamycin and its detection method, which is applied in the field of detection of the dissolution rate of acetylkitamycin capsules. It can solve the problems of unbreakable swelling of the preparation, affecting the measurement, and the dissolution measurement method needs to be optimized, so as to overcome the problem of reduced release in vitro. Effect

Active Publication Date: 2012-07-04
武汉人福药业有限责任公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the long-term storage process, the gelatin in the capsule shell will appear cross-linking and bonding over time, which will cause the preparation to swell and not break, which limits the release of the drug and affects the determination of the in vitro dissolution of the capsule preparation. However, there are related studies It shows that the in vivo bioavailability of the capsules whose in vitro dissolution rate decreased due to gelatin cross-linking did not change significantly, and the dissolution rate in the gastrointestinal tract environment in vivo did not decrease.
Therefore, the dissolution determination method needs to be optimized to more objectively reflect the dissolution behavior in vivo

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for detecting dissolution rates of acetylkitasamycin capsules
  • Method for detecting dissolution rates of acetylkitasamycin capsules
  • Method for detecting dissolution rates of acetylkitasamycin capsules

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Embodiment 1 Acetylkitamycin Capsules Dissolution Determination

[0020] Preparation of pepsin solution: Take 16.4mL of dilute hydrochloric acid with a mass percentage concentration of 9.5-10.5%, add about 800mL of water and 1:15,000 units of pepsin (15,000 units of pepsin activity per 1g) 6-12g or 1:3000 units of pepsin (Each 1g of pepsin activity is 3000 units) 10g, dissolve and shake well, add water to dilute to 1000mL, that is.

[0021] Preparation of the test solution: get 6 capsules of acetylkitasamycin (about 200,000 units / grain of acetylkitasamycin), take 900mL of pepsin solution as the dissolution medium, adopt the second method of Appendix XC of the Chinese Pharmacopoeia in 2010, The rotating speed is 100 revolutions per minute. When operating according to the law for 60 minutes, take an appropriate amount of the solution, filter it, and accurately measure 3 mL of the subsequent filtrate and put it in a 50 mL measuring bottle. Contains 12 to 15 units of a...

Embodiment 2

[0035] Embodiment 2 is the dissolution rate measurement when taking hydrochloric acid solution as dissolution medium

[0036] Take 6 capsules of acetylkitasamycin capsules (200,000 units / capsule), and use the slurry method for determination, use 900mL hydrochloric acid solution as the dissolution medium, and the rotation speed is 100 revolutions per minute. When operating according to the law to 60 minutes, take an appropriate amount of the solution, filter , accurately measure 3mL of the continued filtrate and put it in a 50mL measuring bottle, use 1.56-1.72‰ hydrochloric acid solution to make up the volume, and dilute it into an acetylkitamycin solution containing about 13 units per 1mL; another amount equivalent to about 167000 One unit of acetylkitasamycin capsule content, dissolved with 1.56-1.72‰ hydrochloric acid solution and diluted to 250mL, took 2mL of the above dilution solution into a 100mL measuring bottle, added 6mL of filtered pepsin solution, diluted with 1.56-1...

Embodiment 3

[0039] The impact of embodiment 3 pepsin addition on dissolution rate measurement

[0040] Take 6g, 8g, 10g, and 12g of pepsin with an activity of 1:15000, dissolve them in hydrochloric acid solution with a mass percentage concentration of 1.56-1.72‰, and dilute to 1000mL to obtain dissolution media containing different pepsin solubility, which are respectively recorded as medium A , Medium B, Medium C, and Medium D, respectively use dissolution medium A, medium B, medium C, and medium D to measure the dissolution rate of acetylkitamycin capsules according to the method of Example 1. The measurement results are shown in Table 3

[0041] Table 3: The effect of the amount of pepsin on the dissolution test

[0042]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
absorption wavelengthaaaaaaaaaa
Login to view more

Abstract

The invention discloses a method for detecting dissolution rates of acetylkitasamycin capsules. The method is characterized by taking pepsin liquid as the dissolution medium for detection and comprises the steps of preparing the pepsin liquid, preparing test sample solution, preparing control sample solution, preparing blank solution and carrying out determination. The method has the technical effects of reflecting in vivo dissolution release behaviours of the acetylkitasamycin capsules more objectively, solving the problem that in vitro release is reduced because of crosslinking of gelatine in capsule materials and objectively reflecting the actual dissolution behaviour and quality of the preparation.

Description

technical field [0001] The invention relates to a method for detecting the dissolution rate of acetylkitamycin capsules. Background technique [0002] Acetylkitamycin Capsules is a macrolide antibiotic drug, mainly used for various infections caused by sensitive Gram-positive bacteria, especially for upper and lower respiratory tract infections caused by Staphylococcus aureus, pneumococcus and Skin and soft tissue infection. In the long-term storage process, the gelatin in the capsule shell will appear cross-linking and bonding over time, which will cause the preparation to swell and not break, which limits the release of the drug and affects the determination of the in vitro dissolution of the capsule preparation. However, there are related studies It was shown that the in vivo bioavailability of the capsules whose in vitro dissolution rate decreased due to gelatin cross-linking did not change significantly, and the dissolution rate did not decrease in the gastrointestinal...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): G01N21/33
Inventor 刘红华郭芬张传涛陈磊
Owner 武汉人福药业有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products